Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
The majority of drugs are typically orally administered. The journey from drug discovery to approval is often long and expensive, involving multiple stages. A major challenge in the drug development process is drug-induced liver injury (DILI), a condition that affects the liver, the organ responsibl...
Saved in:
Main Authors: | Dileep G. Nair, Ralf Weiskirchen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/47/1/7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct-Acting Antivirals in Hepatitis C Treatment for Renal Impairment: Liver Safety Concerns and Effectiveness in Peritoneal Dialysis
by: Hsuan-Yu Hung, et al.
Published: (2024-12-01) -
Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01) -
Biocompatible Heterogeneous Packaging and Laser-Assisted Fluid Interface Control for In Situ Sensor in Organ-on-a-Chip
by: Yu-Hsuan Lin, et al.
Published: (2024-12-01) -
Drug-induced liver injuries (Part 1)
by: S. F. Galimova
Published: (2012-06-01) -
Drug-induced liver injuries
by: S. F. Galimova
Published: (2014-07-01)